Guilherme Nader Marta: Global study on young BRCA carriers with breast cancer

Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared a post by Elisa Agostinetto, on X:

”Proud to be part of this large global study on young BRCA carriers with breast cancer Lobular tumors  grade 1/2 (58% vs. 22%), stage III (30% vs. 18%), and luminal A-like (42% vs. 12%), and linked to BRCA2 (71%) No significant difference in DFS or OS compared to IDC.”

Quoting Elisa Agostinetto‘s post:

”Now out in ESMO Open our study on characteristics and clinical outcomes of breast cancer in a cohort of 4,628 young BRCA carriers according to tumor histology

Low incidence of lobular, having higher disease stage and more BRCA
PVs.”

Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology.

Authors: E. Agostinetto, M. Bruzzone, A.-S. Hamy, H. J. Kim, C. Chiodi, R. Bernstein-Molho, S. Linn, K. Pogoda, E. Carrasco, F. Derouane, J. Bajpai, G. Nader-Marta, N. Lopetegui-Lia, A. H. Partridge, L. Cortesi, C. Rousset-Jablonski, F. Giugliano, T. Renaud, A. Ferrari, S. Paluch-Shimon, R. Fruscio, W. Cui, S. M. Wong, C. Vernieri, K. J. Ruddy, M. V. Dieci, A. Matikas, M. Rozenblit, D. Aguilar y Mendez, L. De Marchis, R. Borea, F. Puglisi, M. Pistelli, J. Kufel-Grabowska, R. Di Rocco, E. Mariamidze, F. Atzori, H. R. Kourie, L. Popovic, E. de Azambuja, E. Blondeaux, M. Lambertini.

Source: Guilherme Nader Marta/X and Elisa Agostinetto/X

Elisa Agostinetto, is a medical oncologist, specializing in breast cancer research. Elisa Agostinetto is a Medical Research Fellow at the University Hospital of Brussels since November 2021. Additionally, she has serves as a Clinical Research Fellow at Jules Bordet Institute. Her work focuses on clinical research in oncology, likely involving various aspects of cancer treatment and patient care. Actively engaged in professional societies like ESMO, ASCO, and BSMO, she also contributes as a young investigator in the EORTC Breast Cancer Working Group and as a Committee member of the Young Cancer Professionals within the European Cancer Organization.